Poseida Therapeutics Inc (PSTX)
2.54
+0.07
(+2.83%)
USD |
NASDAQ |
Nov 04, 16:00
2.535
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Profit Margin (Quarterly): -120.8% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -120.8% |
| March 31, 2024 | -86.26% |
| December 31, 2023 | -101.4% |
| September 30, 2023 | -339.8% |
| June 30, 2023 | -137.2% |
| March 31, 2023 | -375.6% |
| Date | Value |
|---|---|
| December 31, 2022 | -331.5% |
| September 30, 2022 | 60.54% |
| June 30, 2022 | -1.59K% |
| March 31, 2022 | -4.05K% |
| December 31, 2021 | 4.70% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.05K%
Minimum
Mar 2022
60.54%
Maximum
Sep 2022
-642.5%
Average
-137.2%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| MaxCyte Inc | -89.89% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -111.0% |
| Return on Assets | -39.75% |
| Return on Invested Capital | -70.39% |
| Operating Margin (Quarterly) | -122.3% |
| Return on Net Operating Assets | -194.5% |